← Back to Clinical Trials
Recruiting NCT06396260

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

Trial Parameters

Condition Amyotrophic Lateral Sclerosis
Sponsor Aalborg University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2024-05-26
Completion 2026-10-31
Interventions
Diffusion Kurtosis Imaging (DKI)Resting State Magnetoencephalography

Brief Summary

The investigators aim to elucidate characteristics of structural and functional brain connectivity in patients with amyotrophic lateral sclerosis (ALS) and pseudobulbar affect (PBA) using diffusion kurtosis imaging (DKI) and magnetoencephalography (MEG).

Eligibility Criteria

Inclusion Criteria: * Diagnosed with ALS in the last 6 months according to Gold Coast Criteria Exclusion Criteria: * \- Lack of ability to answer survey through own ability or through a surrogate, for example by hand controlled, eye-controlled computer and/or tablet, or through telephone interview. * Lack of ability to cooperate. * Pregnancy * Drug addiction defined as the non-prescribed use of cannabis, opioids, or other narcotics. * Alcohol addiction defined as over 21 units weekly. * Lesional neurological diseases, such as stroke, tumor or multiple sclerosis * Epilepsy * Neurodegenerative diseases other than ALS * Severe psychiatric disease such as major depression disorder, bipolar disease or schizophrenia * Contraindication for MRI and MEG scan according to hospital guidelines * Severe liver or kidney disease * Dysregulated heart disease * Ongoing treatment with any antidepressants or any antipsychotics at recruitment. * Diagnosed with frontotemporal dementia.

Related Trials